Defective cytokinesis can also result in aneuploidy in cancer cells, which fosters genomic instability that can drive tumorigenesis [85, 87] and thus may represent a further mechanism through which IER2-induced senescence might conceivably promote cancer progression if cells are subsequently able to re-enter the cell cycle. The gene discussed is IER2; the disease is cancer.